Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 444 results for "sun pharmaceutical industries"

Sun Pharma to focus on R&D after Ranbaxy buyout
Business Today India

India's Sun Pharma completes $3.2bn merger deal with Ranbaxy

India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal. Sun has started integration of the acquired business that allows the firm to become the fifth largest specialty generic pharmaceutical ... Pharmaceutical Technology, 1 day ago
Sun Pharma to focus on R&D after Ranbaxy buyout Business Today India, 1 day ago

39 images for sun pharmaceutical industries

Sify, 2 days ago
Reuters, 2 days ago
Financial Express, 3 days ago
Sify, 3 weeks ago
Money Today, 2 days ago
India Infoline, 2 days ago
IBNLive India News, 2 days ago
Business Today India, 2 days ago
Money Today, 1 month ago
Reuters, 3 weeks ago

We want to focus on growing faster: Dilip Shanghvi

Shanghvi says the Ranbaxy acquisition doesn't preclude Sun Pharma from making more large acquisitions. Photo: Bloomberg On Wednesday, as the Sun Pharmaceutical Industries Ltd-Ranbaxy Laboratories Ltd merger closed, the former's founder Dilip S.
 Livemint.com1 day ago Sun Pharma wraps up Ranbaxy deal  Nikkei Asian Review2 days ago India's Sun Pharma open to large acquisitions post Ranbaxy deal  Reuters UK2 days ago Life Post-Ranbaxy Laboratories? Sun Pharma Holds On to $300 Million and Hunts for More M&As  BioSpace2 days ago

Sun Pharma MD uncomfortable with tag of India's richest

Dilip Shanghvi, founder and managing director of Sun Pharmaceuticals, tells Soma Das and Divya Rajagopal that he would rather focus on concrete objectives like improving performance than attend to amorphous concepts like 'corporate culture' while ...
 Economic Times1 day ago Sun Pharma's Dilip Shanghvi may enter wind energy biz with a stake in Suzlon  First Post.com1 month ago Shanghvi springs a surprise with payment banks bid  Rediff.com1 month ago
Money Today

RIP Ranbaxy

Senior Editor P.B. Jayakumar Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries. Such mergers and acquisitions are common in the global pharmaceutical industry. Many big global companies of ...
 Business Today India1 day ago

Pharma, financial firms lead Nifty stocks in FY15

Information technology (IT) stocks such as HCL Technologies Ltd and Tech Mahindra Ltd, which had led the gainers pack in financial year 2013-14, are missing in the top gainers list this year. Photo: Hemant Mishra/Mint Mumbai: Drug makers and ...
 Livemint.com1 day ago
NDTV Profit

Bain Capital-backed Emcure to buy half a dozen products from Sun Pharma-Ranbaxy

The Competition Commission of India (CCI) has approved the acquisition of around half a dozen products currently made and sold by Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd to privately held Emcure Pharmaceuticals Ltd. The ...
 VC Circle3 days ago Sun Pharma, Ranbaxy get CCI's nod to sell seven brands to Emcure Pharma  Indian-Commodity3 days ago Sun Pharma, Ranbaxy Gain After Competition Commission's Nod  NDTV Profit3 days ago Sun-Ranbaxy gets CCI nod to sell 7 brands to Emcure  Times of India4 days ago

UPDATED: Sun winds up Ranbaxy deal

Sun Pharmaceuticals and Ranbaxy Laboratories have jumped the final hurdle in their merger with government approval of a sale of 7 of their branded drugs to fellow India drugmaker Emcure Pharmaceuticals. A press conference featuring Sun Managing ...
 FiercePharma2 days ago Sun Pharma, Ranbaxy up 2% on final CCI nod for merger deal  Money Control3 days ago Emcure to buy divested assets of Sun Pharma and Ranbaxy  Livemint.com4 days ago Punjab & Haryana High Court clears Sun-Ranbaxy merger  PharmaBiz2 weeks ago

Sun Pharma completes Ranbaxy deal

Shares of Sun Pharma rose as much as 2.4% in intra-day trade on Wednesday, while those of Ranbaxy jumped 2.1%. Photo: Hemant Mishra/Mint Mumbai: Sun Pharmaceutical Industries Ltd, India's most valuable drug maker, has completed the $3.2 billion ...
 Livemint.com2 days ago Sun Pharma gets US FTC clearance for Ranbaxy acquisition  The Hindu3 days ago Sun Pharma, Ranbaxy USD 4 bn merger deal gets US FTC nod  Deccan Herald1 month ago Sun Pharma gets US trade regulator nod for Ranbaxy deal  Rediff.com1 month ago

BPCL flares up 2% on NSE

Sun Pharmaceuticals was broadly strong in the Wednesday morning session. It led the pack on the NSE as well, trading at Rs 1,057.55 as against Rs 1,037.15 at close yesterday. This was a gain of 1.97 per cent. BPCL flared up 1.87 per cent to trade ...
 Hindu Business Line2 days ago Lupin leads the pack on NSE  Hindu Business Line1 week ago

Sun Pharma, RComm, Wockhardt to get astro supprort: Gupta

According to Satish Gupta of astrostocktips, pharma stocks like Ranbaxy Laboratories, Sun Pharmaceutical Industries, Wockhardt, Strides Arcolab and Aurobindo Pharma will get astro suppport.
 Money Control2 days ago Sun Pharma, Lupin, Cipla to get astro support: Gupta  Money Control1 week ago Sun Pharma, Cipla, Exide to get astro support: Gupta  Moneycontrol.com2 weeks ago Exide, Motherson Sumi, Cipla to get astro support: Gupta  Moneycontrol.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
Get updated on latest news & your favorite topics right in your inbox!
More     Less